Patients How the rise of medical device use in pharma R&D is driving ... As wearable technologies continue to rapidly develop, the use cases for wearable devices evolve and expand.
Digital Digital measures and pre-competitive collaborations Digital measures from a patient’s home and known environments offer greater health insights.
News JPM: AbbVie pays $650m upfront for RemeGen cancer drug AbbVie joins the ranks of companies developing cancer drugs that target both PD-1 and VEGF, via a $5.6bn licensing deal with China's RemeGen.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
